Target Audience

This course is intended for all healthcare staff involved in the management of high risk medicines.

Duration

The course is designed to take around half an hour to complete.

Certificate

On successful completion of the assessments you can download a certificate of completion.

Compliance

This course aligns with the National Safety and Quality Health Service Standards, Second Edition – Standards 1, 2, 4 & 6.

Disclaimer

This course content was developed by the Australian Commission on Safety and Quality in Health Care and is protected by copyright under a Creative Commons Attribution-Non-Commercial-Share Alike (BY-NC-ND) 4.0 International License.

The content is provided in good faith by the Commission for information purposes. It is not a substitute for, and is not intended to replace, any specific policies, guidelines or requirements for your local health network or health service.

The Commission does not accept any legal liability or responsibility for any injury, loss or damage incurred by the use of, or reliance on, this information.

Australian Commission on Safety and Quality in Health Care: www.safetyandquality.gov.au, including:

• High Risk Medicines
• Medication Charts
• ACSQHC Best Possible Medication History
• VTE Prevention Resource Centre

NPS MedicineWise: www.nps.org.au

• provides evidence based information on medicines for consumers and health professionals, including ‘Anticoagulant medicines’
• provides online learning resources including on Medication Safety and the National Inpatient Medication Chart

Medication Safety Self Assessment for Antithrombotic Therapy in Australian Hospitals at: mssa.cec.health.nsw.gov.au/at2/MSSAT_introduction.html

• designed to heighten awareness of safe use of antithrombotic agents; and create a baseline of efforts to enhance safety with these agents and evaluate these efforts over time.

National QUM Indicators for Australian Hospitals Set 1: Antithrombotic therapy at: www.ciap.health.nsw.gov.au/nswtag/pages/indicators-set-1.html

• process indicators to measure quality use of antithrombotic therapy.

Institute for Safe Medication Practices: www.ismp.org

• Improving Medication Safety with Anticoagulant Therapy at: www.ismp.org/sites/default/files/attachments/2017-11/ISMP128-Antithrombotic%20SA-021017.pdf

For further resources on high risk medicines, see the Introduction to High Risk Medicines
e-learning course.

Content team

Medicines and Technology Branch (MTP), SA Health:

• Naomi Burgess, Director
• Anita Abarno, Senior Pharmacist, Medication Safety
• Kaye Barratt, Senior Pharmacist, Medicines Programs

SA Health would also like to acknowledge and thank the following:

• Carolyn Field, Women’s and Children’s Health Network
• Kirsty Scarborough, Central Adelaide Local Health Network
• Kerrie Westaway, Medical Writer, Sansom Institute, University of South Australia (previously Senior Project Officer, Medication Safety, Medicines and Technology Policy and Programs, SA Health)
• Royal Adelaide Hospital Pharmacy Department
• Women’s and Children’s Hospital Pharmacy Department
• Members of the Anticoagulant Toolkit Working Group and reviewers of the Anticoagulant Toolkit